Data in WHO HQ as of 17 Apr 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this document.

Slides:



Advertisements
Similar presentations
1 |1 | Countries using and planning to introduce IPV July 2014 status report This slide deck provides a summary per country on the status of planning for.
Advertisements

1 |1 | Countries using and planning to introduce IPV.
Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV.
Vaccine in National Immunization Programme Update March 2015.
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV.
World Health Organization
1 |1 | Countries using and planning to introduce IPV.
TITLE from VIEW and SLIDE MASTER | August 7, |1 | Countries with Hib vaccine in the national immunization programme; and planned introductions *
WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region.
WHO RAP Team: Perspective and Update WORKSHOP ON ANALYZING THE POLIO ERADICATION ENDGAME, Seattle, 1-2 July 2015.
World Health Organization
Polio Update Pre Tender Meeting 11 th December 2008 UNICEF Supply Division.
1 |1 | Countries using and planning to introduce IPV.
Adverse Events following Immunization (AEFI) Monitoring and Causality Assessment An Overview Department of Disease Control Ministry of Public Health Bureau.
Highlights of New WPV Cases 34 new cases in 5 countries 14 cases (14 W3) but no new district in India Most recent date of onset 03 Oct 1 case (W1) but.
Data in WHO HQ as of 09 October 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this.
NVAC W. R. Dowdle. Laboratory Containment of Wild Poliovirus in the United States Phase I National Survey and Inventory Final Report January.
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV and the global status of bOPV registration Countries using and planning to introduce IPV and the global.
1 |1 | Countries using and planning to introduce IPV and the global status of bOPV registration.
1 |1 | Countries using and planning to introduce IPV and the global status of bOPV registration.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
Global Programme on Evidence for Health Policy The use of GIS in the Global Programme on Evidence for Health Policy (GPE) Meeting on Cartography and Geographic.
Vaccine in National Immunization Programme Update April 2016.
World Health Organization
Data quality for polio eradication: Accuracy & reliability
Perspective and Update
SAGE 2010 Sampling Distribution
Global Polio Eradication: Current Status, Challenges and Future Directions Steven Wassilak, MD Centers for Disease Control and Prevention, Atlanta APHA.
Measles disease An acute viral infection spread via respiratory secretions or aerosols Classic manifestations: Maculopapular rash Fever +cough + coryza/conjuctivities.
reporting rate of discarded cases* per 100'000 population**
World Health Organization
Monthly Distribution of Wild Poliovirus Cases1,
SAGE 2009 Sampling Distribution
06/12/2018 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
Countries Having Introduced Hib Vaccine
Countries Having Introduced Hib Vaccine and Infant Hib Coverage, 2010
Circulating Vaccine-derived Poliovirus*, last 6 months
Sampling Distribution
15/01/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.
Non-polio AFP Rate July 2014 – June 2015 July 2015 – June 2016
Monthly Distribution of Wild Poliovirus Cases1,
(70 countries or 36%) (23 countries or 12%)
Countries with Genotype data available
Countries Using Hib Vaccine in National Immunization Schedule in 2010 and Countries Approved for GAVI Support for Use from 2011 Onwards Yes (166 countries.
World Health Organization
24/02/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
World Health Organization
Onset of most recent WPV1 Case Number of WPV infected districts
08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
Countries having introduced HepB vaccine
No new positives this week
05/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.
Mapping Levels of Palliative Care Development: A Global Update
Countries Using Mening Vaccine in National Immunization Schedule 2011
- Use same categories as for bar chart below Introduced Without GAVI
Onset of most recent case Number of infected districts
04/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1contacts of positive AFP cases, community, healthy children.
Meningitis/Encephalitis Surveillance Countries reporting to WHO Network or with Other (non-WHO Network) Surveillance Activities WHO Network (46 member.
16/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
Circulating Vaccine-derived Poliovirus1,
27/08/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
2,100 4,200 1,050 Kilometers < 90% (75 countries or 39%)
World Health Organization
World Health Organization
Presentation transcript:

Data in WHO HQ as of 17 Apr 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this document do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO All rights reserved new officially reported WPV cases 6 cases (5 W1, 1 W3) and 4 new districts in Nigeria New district refers to areas that were previously without wild polio virus in 2012.

Wild Poliovirus 1, Previous 12 Months* Country with WPV case in previous 6 months Endemic country Country with WPV case 6-12 months ago Wild virus type 1 Wild virus type 3 Wild virus type 1/3 1 Excludes viruses detected from environmental surveillance and vaccine derived polioviruses. *18 Apr 2011 – 17 Apr 2012 Data in WHO HQ as of 17 Apr 2012

Endemic country Wild Poliovirus 1, Previous 6 Months* 1 Excludes viruses detected from environmental surveillance and vaccine derived polioviruses. Country with WPV case in previous 6 months *18 Oct 2011 – 17 Apr 2012 Wild virus type 1 Wild virus type 3 Wild virus type 1/3 Data in WHO HQ as of 17 Apr 2012

Wild Poliovirus Infected Districts 1, Previous 6 Months* District infected with wild polio virus type 1 District infected with wild polio virus type 3 District infected with both types of wild poliovirus 1 Excludes viruses detected from environmental surveillance and vaccine derived polioviruses. *18 Oct 2011 – 17 Apr 2012 Data in WHO HQ as of 17 Apr 2012

Data in WHO HQ as of 10 Jan 2012 Wild Poliovirus Data in WHO HQ as of 17 Apr 2012

Wild Poliovirus Cases by Type 2011 & Year to Date Comparison Data in WHO HQ as of 17 Apr 2012

1 Circulating Vaccine-derived poliovirus (cVDPV) is associated with 2 or more cases of AFP. Niger 2006, Niger 2009, Niger 2010, Chad 2010 cVDPVs are linked to the Nigeria outbreak. VDPV type 2 cases with greater than 5nt difference from sabin in VP1 and VDPV types 1 and 3 cases with greater than 9nt difference from sabin in VP1 are reported here. Figures exclude VDPV from non-AFP sources. Nigeria figures include the following cases with WPV1/cVPDV 2 mixture: 2005 – 2, , , 2008 – 3, , 2011 – 1; WPV3/cVPDV2 mixture *Figures include multiple emergences and transmission chains. Circulating Vaccine-derived Poliovirus 1, Data in WHO HQ as of 17 Apr 2012

Monthly distribution of cases by country *Circulating Vaccine-derived poliovirus (cVDPV) is associated with 2 or more cases of AFP. VDPV type 2 cases with greater than 5nt difference from sabin in VP1 and VDPV type 1 and 3 cases with greater than 9nt difference from sabin in VP1 are reported here. Figures exclude VDPV from non-AFP source. Figures may include different chains of transmission. Circulating Vaccine-derived Poliovirus*, Previous 6 Months** cVDPV2 (22 cases) cVDPV1 (0 case) cVDPV3 (0 case) Data in WHO HQ as of 17 Apr 2012 Number of cVDPV cases *18 Oct 2011 – 17 Apr 2012

Comparison of 2011 and 2012 Data Year to Date (01 Jan to 17 Apr) Data for 2011 as of 19 Apr 2011 and for 2012 as of 17 Apr Data in WHO HQ as of 17 Apr 2012

AFP Cases Pending Classification, 2011 Top 10 countries with cases pending classification: India (1448), Mexico (106), Pakistan (63), Nigeria (52), Philippines (50), Ethiopia (26), Malawi (26), Niger (21), Kazakhstan (18), Guatemala (16) Data in WHO HQ as of 17 Apr 2012